Jellagen company
Collagen-based innovation that addresses complex tissue engineering and regenerative medical needs, helping to shape next-generation medical treatments alongside current and future scientific research.
%20.jpg)
Founded Date:
7-5
Last Funding Type:
Series B
Headquarters:
Pembroke Dock, Pembrokeshire, United Kingdom
Investors Number:
5
Technology:
Regenerative Medicine
Employee Number:
1-10
Industry:
Regenerative Medicine
Estimated Revenue:
$1M to $10M
Number Of Exists:
Series B
Funding Status:
Early Stage Venture
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
£5.7M